Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Paul J. Hastings Files Initial Ownership Statement at Azora Therapeutics

Paul J. Hastings submitted an initial statement of beneficial ownership with the SEC on November 10, 2026, in connection with an event date of November 3, 2026, disclosing his status as a director of Azora Therapeutics, Inc. (DE), listed on NASDAQ:AZR.

Anjali Anand | 10 November 2026

Atossa Therapeutics Q3 2026: $20.6M Cash, $23.7M Nine-Month Loss

Atossa Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing a net loss of $23.718 million for the nine months ended September 30, 2026, with cash and cash equivalents of $20.574 million at quarter end.

Aditi Sarkar | 10 November 2026

Nanox Board Approves 25%-30% Operating Expense Cut Plan

Nano-X Imaging Ltd filed a Form 6-K with the SEC on November 9, 2026, disclosing that its Board of Directors approved a strategic realignment and efficiency plan targeting a 25%-30% annualized reduction in operating expenses, alongside a global workforce reduction and four renewed strategic …

Aakashdeep | 10 November 2026

Nova CFO to Speak at Two Investor Conferences in November-December 2026

Nova Ltd. filed a Form 6-K on November 10, 2026, announcing that Chief Financial Officer Guy Kizner will participate in two investor conferences during November and December 2026.

Shwetambri Chauhan | 10 November 2026

Aida Habtezion Files Initial Ownership Statement With Azora Therapeutics

Director Aida Habtezion filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 10, 2026, reporting her initial ownership position in Azora Therapeutics, Inc. as of the event date of November 3, 2026.

Anjali Anand | 10 November 2026

Thomas M. Soloway Files Initial Ownership Statement at Azora Therapeutics

Thomas M. Soloway, a newly reported director at Azora Therapeutics, Inc., filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 10, 2026, reflecting an event date of November 3, 2026.

Aakashdeep | 10 November 2026

Why Is Bluejay Diagnostics (NASDAQ:BJDX) Dropping 9.24% Pre-Market on Tuesday?

The release gave no reason for the split and no Nasdaq deficiency details, so the motive is not confirmed. As general context, companies often use reverse splits to lift the share price above the USD 1.00 minimum bid that Nasdaq requires, yet the split …

Vinay Lochav | 10 November 2026

Why Did Akamai (NASDAQ:AKAM) Slip 3.37% on a USD 2.2 Billion Convertible Note Offering?

Key HighlightsAkamai (NASDAQ:AKAM) closed down 3.37% on November 9, 2026, after proposing USD 2.2 billion of convertible senior notes, split into USD 1.1 billion due November 15, 2028 and USD 1.1 billion due November 15, 2031.The notes priced with a 1.00% coupon on both …

Vinay Lochav | 10 November 2026

Why Is The Children's Place (NASDAQ:PLCE) Falling 9.24% Pre-Market on Tuesday?

The catalyst is the filing itself. As general context, in a section 363 sale the buyer pays creditors first, and common shareholders rank last, soEquityoften receives little or nothing if proceeds do not cover secured debt. Bids are due December 9, 2026, and no …

Vinay Lochav | 10 November 2026

Why Did Dropbox (NASDAQ:DBX) Fall 6% After Launching USD 1 Billion of Convertible Notes?

Key HighlightsDropbox (NASDAQ:DBX) closed down 6% on November 9, 2026, after announcing a private offering of USD 1 billion of convertible senior notes due 2031.The deal was upsized and priced at USD 1.1 billion with a 1.25% coupon and an initial conversion price of …

Vinay Lochav | 10 November 2026
Support

Hi! How can we help you today?

Loading…